Top 10 Managed Healthcare Companies To Invest In 2014

Profile: He is an expert on financial derivatives and risk management
Known for: His book �raders, Guns and Money�was almost prescient in the way it foresaw the troubles of corporate India with derivatives in 2007

Investors approach investment in the same way that Woody Allen approached the subject of divinity: �f only God would give me some clear sign! Like making a large deposit in my name in a Swiss bank.�For the last 20 years, despite occasional lapses, the mysterious investment gods have given clear signs of their existence �showering munificent high returns on investors.

As smart investors know, investment genius is a long position, leverage and a rising market. A rising tide, as they say, lifts all boats. But that may now be all in the past.

The global economic recovery is stalling. Major economies, such as the US, Europe and Japan remain mired in slow, low growth as they deal with legacy problems of debt, banking problems and deep-seated structural imbalances. Germany and emerging market economies, like China and India, which have contributed the bulk of global growth since 2008, are showing signs of slowing.

Hot Internet Companies To Buy Right Now: IPC The Hospitalist Company Inc.(IPCM)

IPC The Hospitalist Company, Inc., through its subsidiaries, provides hospitalist services in the United States. It engages in providing, managing, and coordinating the care of hospitalized patients and serves as the inpatient partner of primary care physicians and specialists. As of December 31, 2011, the company with its 1,201 affiliated hospitalists, including physicians, nurse practitioners, and physician assistants that are organized into medical group practices, provided hospitalist solutions at approximately 365 hospitals, and 550 other inpatient and post-acute care facilities primarily in 25 states. It also offers administrative and professional services, including information management system, transition management, regional management, recruiting, training, financial reporting, billing and collection, risk management, and compliance services to affiliated hospitalists. The company serves patients, primary care physicians, specialists, acute care hospitals, alter native sites of inpatient care, and health plans. IPC The Hospitalist Company, Inc., formerly known as InPatient Consultants Management, Inc., was founded in 1995 and is headquartered in North Hollywood, California.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Equities Trading DOWN
  Shares of IPC The Hospitalist Company (NASDAQ: IPCM) were down 2.60 percent to $56.98 after Credit Suisse downgraded the stock from Outperform to Neutral.

Top 10 Managed Healthcare Companies To Invest In 2014: Energy Select Sector SPDR Fund (XLE)

Energy Select Sector SPDR Fund (the Fund) seeks to provide investment results that correspond to the price and yield performance of the Energy Select Sector of the S&P 500 Index (the Index). The Index includes companies that primarily develop and produce crude oil and natural gas, and provide drilling and other energy-related services.

The Fund utilizes a passive or indexing investment approach to invest in a portfolio of stocks that seek to replicate the Index. The Fund�� investment advisor is SSgA Funds Management, Inc.

Advisors' Opinion:

• [By Claudia Assis]

  The SPDR Energy Select Sector (XLE) , an exchange-traded fund focused on energy names, fell 0.4%.

• [By Wallace Witkowski]

  Given the weak earnings outlook, some investors are saying the recent spike in energy stocks and exchange-traded funds like the Energy Select Sector SPDR (XLE) is a classic late-cycle play in an aging bull market. Others see it as a smart bet because of innovation in the industry and higher crude-oil and natural-gas prices. Those higher prices, however, slipped this past week with oil seeing its worst weekly drop since mid-March and natural-gas prices down 2% on the week.

• [By Claudia Assis]

  The SPDR Energy Select Sector (XLE) �exchange-traded fund, which focuses on energy names, retreated 0.9%.

• [By Stephen Leeb]

  The bellwether S&P Energy Select Sector (XLE), has done very well so far this year, keeping pace with the overall market's push upwards; XLE remains a buy.

Top 10 Managed Healthcare Companies To Invest In 2014: Achillion Pharmaceuticals Inc.(ACHN)

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases. The company focuses on the development of antivirals for the treatment of chronic hepatitis C; and the development of antibacterials for the treatment of resistant bacterial infections. Its drug candidates for the treatment of chronic HCV include ACH-1625, a protease inhibitor, which is in phase IIa clinical trial for the treatment of chronic HCV; ACH-2684, a pangenotypic protease inhibitor, which is in phase I clinical trial for the treatment of chronic HCV infection; and NS5A inhibitors for the treatment of chronic HCV infection, including ACH-2928, which is to enter a phase I clinical trial, as well as various additional NS5A inhibitors in preclinical development. Its pipeline of product candidates also includes ACH-702 and ACH-2881 for drug resistant bacterial infections; elvucitabine for HIV infection; and AC H-1095 for HCV infection. The company was founded in 1998 and is based in New Haven, Connecticut.

Advisors' Opinion:

• [By Sean Williams]

  In terms of clinical updates, hepatitis-C-focused biotech Achillion Pharmaceuticals (NASDAQ: ACHN  ) announced updated midstage results for its lead compound, ACH-3102, on Tuesday. In trials of genotype-1b treatment naive patients, ACH-3102 plus a ribavirin delivered a 75% success rate in end-of-treatment virologic response. The problem with these results is that not only is Achillion far behind its all-oral peers in terms of development, but its 75% success rate trailed that of Gilead Sciences' Sofosbuvir, which delivered 100% success rates in some of its late-stage trials featuring genotype-1 patients.

Top 10 Managed Healthcare Companies To Invest In 2014: HNI Corp (HNI)

HNI Corporation, incorporated in 1944, is a provider of office furniture and hearth products. The Company operates in two segments: office furniture and hearth products. A broad office furniture product offering is sold to dealers, wholesalers, national office product distributors, end-user customers, and federal, state and local governments. Hearth products include a range of gas, electric, wood and biomass burning fireplaces, inserts, stoves, facings and accessories. These products are sold through a national system of dealers and distributors, as well as Corporation-owned distribution and retail outlets. It manufactures office furniture in Alabama, Georgia, Illinois, Indiana, Iowa, Minnesota, New York, North Carolina, Texas and China. The Company manufactures hearth products in Iowa, Maryland, Minnesota, Washington and Pennsylvania. On November 14, 2011, the Company acquired Sagus International, Inc. (Sagus), a designer and manufacturer of educational furniture solutions. In August 2012, the Company BP Ergo Limited, a manufacturer and marketer of office furniture in India.

Eight operating units, marketing under various brand names, participate in the office furniture industry. These operating units include The HON Company, Allsteel Inc., Maxon Furniture Inc., The Gunlocke Company L.L.C., Paoli Inc., Hickory Business Furniture, LLC (HBF), Sagus and HNI Hong Kong Limited (Lamex). The operating unit Hearth & Home Technologies Inc. (Hearth & Home) participates in the hearth products industry. The retail and distribution brand for this operating unit is Fireside Hearth & Home. HNI International Inc. (HNI International) sells office furniture products manufactured by the Company�� operating units in select markets outside the United States and Canada. With dealers and servicing partners located in more than 50 countries, HNI International provides project management services virtually worldwide. The Company distributes its products through a network of independent office furniture dealers,! office products dealers, wholesalers and retailers. The Company is a supplier of office furniture to the nationwide distributors of office products.

Office Furniture

The Company designs, manufactures and markets a range of office furniture in four categories: storage, including vertical files, lateral files and pedestals; seating, including task chairs, executive desk chairs, conference/training chairs, side chairs and educational chairs and desk combinations; office systems (modular and moveable workspaces with integrated work surfaces, space dividers and lighting), and desks and related products, including tables, bookcases and credenzas. Its products are sold under the brand names, such as HON, Allsteel, Maxon, Gunlocke, Paoli, HBF, Artco Bell, Midwest Folding Products, LSI Corporation of America, basyx and Lamex, as well as private labels.

The Company offers a range of storage options designed either to be integrated into its office systems products or to function as freestanding furniture in office applications. The Company sells its freestanding storage through independent office products and office furniture dealers, nationwide chains of office products dealers, wholesalers and national office product distributors. The Company's seating line includes chairs designed for all types of office work.

It offers a complete line of office panel system products for team work settings, private offices and open floor plans. The Company offers whole office solutions, movable panels, storage units and work surfaces that can be installed and reconfigured. The Company and its dealer partners also offer consultative selling and design services for its office system products.

The Company�� offering of desks and related products includes stand-alone steel, laminate and wood furniture items, such as desks, bookshelves, credenzas and mobile desking. The Company's desks and related products are sold to a range of customers from those designing office config! urations ! to small retail and home office purchasers. It offers a range of tables designed for use in conference rooms, private offices, educational institutions, training areas, team work settings and open floor plans. It is North America�� manufacturer and marketer of prefabricated fireplaces, hearth stoves and related products, primarily for the home, which it sells under Heatilator, Heat & Glo, Quadra-Fire and Harman Stove brand names.

The Company�� line of hearth products includes a range of gas, electric and wood burning fireplaces, inserts, stoves, facings and accessories. Heatilator and Heat & Glo are brand in the two segments of the home fireplace market: vented-gas and wood fireplaces. In addition, the Company is also engaged in pellet-burning stoves and furnaces with its Quadra-Fire and Harman product lines, which provide home heating solutions using renewable fuel.

The Company competes with Steelcase Inc., Haworth, Inc., Herman Miller, Inc., Knoll, Inc., The Global Group, Kimball International, Inc., KI, Virco Mfg. Corporation, Teknion Corporation, Travis Industries Inc., Lennox International Inc., Monessen Hearth Systems Co., FMI Products, LLC, Wolf Steel Ltd. (Napoleon) and FPI Fireplace Products International Ltd. (Regency).

Advisors' Opinion:

• [By Ben Levisohn]

  Last week, HNI Corp. (HNI) beat earnings forecasts and promptly fell 3.4%. Raymond James, however, thinks the selloff was undeserved and raised its rating on the office-furniture maker, helping HNI Corp. to make back its loss.

  Raymond James analysts Budd Bugatch and�Bobby Griffin explain why they upgraded HNI Corp.:

  We are upgrading HNI to Outperform from a Market Perform rating and establishing a $36.00 price target following the company�� 1Q14 earnings release and management conference call. As stated in an earlier note, HNI delivered a ��lean��1Q14 EPS beat; and we are puzzled by Thursday�� trading activity. HNI historically trades at a premium to the office furniture peer group, but following the shares��recent pullback (down ~3.5% on Thursday before the Good Friday holiday and down 14% YTD compared to +0.8% for the SPX YTD), this is no longer the case and gives us reason for a more constructive rating.

  Shares of HNI Corp. have gained 4.9% to $35.17 at 1:45 p.m., while Steelcase (SCS) has risen 0.8% to $16.93, Knoll (KNL) has advanced 2.5% to $18.74 and Herman Miller (MLHR) has ticked up 0.3% to $30.57.

• [By Rich Duprey]

  Fireplace and office furniture maker�HNI� (NYSE: HNI  ) �announced yesterday�its second-quarter dividend of $0.24 per share, the same rate it paid for the last four quarters after it raised the payout a penny from $0.23 per share.

• [By John Udovich]

  Small cap office furniture stock Steelcase Inc (NYSE: SCS) jumped 11.66% after beating earnings expectations, meaning it might be time to take a closer look at the stock along with potential office or commercial furniture stock peers like�HNI Corp (NYSE: HNI), Knoll Inc (NYSE: KNL) and Virco Mfg. Corporation (NASDAQ: VIRC). After all, the performance of any company selling office or commercial furniture would tend to give some insights into the office or employment markets.

Top 10 Managed Healthcare Companies To Invest In 2014: Virco Manufacturing Corporation(VIRC)

Virco Mfg. Corporation engages in the design, production, and distribution of furniture for the commercial and education markets in the United States. The company offers seating products, including cantilever chairs, tablet arm chairs, rockers, hard plastic seats, backrests, work surfaces, task chairs, classroom chairs, stack chairs, folding chairs, upholstered stack chairs, plastic stack chairs, and upholstered ergonomic chairs, as well as provides various seating product for students in college, university, other adult education settings, and on high school campuses. It also offers folding and banquet tables, activity tables, office tables, computer tables, and mobile tables, as well as table products for working and learning environments, seminars, and conferences; and computer furniture, including keyboard mouse trays, CPU holders, support columns, desks and workstations, and specialty tables and other products for computing applications. In addition, the company provi des chair desks, combo units, teacher desks, and tablet arm units, as well as a collection returns and credenzas. Further, it offers administrative office furniture, such as desks, returns, and bookcases; laboratory furniture, including steel-based science tables, table bases, lab stools, and steel foot-rings for biology and chemistry classes, and other school and college based lab settings; and mobile furniture comprising mobile tables for school cafeterias and mobile chairs for school settings and offices, as well as provides handling and storage equipment and manufactures stackable storage trucks. The company?s brand portfolio primarily includes ZUMA, ZUMAfrd, Ph.D., I.Q. Virtuoso, Classic Series, Martest 21, Lunada, Plateau, Core-a-Gator, Future Access, Sigma, Metaphor, Telos, TEXT, and Parameter. It also serves convention centers and arenas, hospitality providers, government facilities, and places of worship. Virco Mfg. Corporation founded in 1950 and is based in Torra nce, California.

Advisors' Opinion:

• [By John Udovich]

  Small cap office furniture stock Steelcase Inc (NYSE: SCS) jumped 11.66% after beating earnings expectations, meaning it might be time to take a closer look at the stock along with potential office or commercial furniture stock peers like�HNI Corp (NYSE: HNI), Knoll Inc (NYSE: KNL) and Virco Mfg. Corporation (NASDAQ: VIRC). After all, the performance of any company selling office or commercial furniture would tend to give some insights into the office or employment markets.

Top 10 Managed Healthcare Companies To Invest In 2014: Lithia Motors Inc. (LAD)

Lithia Motors, Inc. operates as an automotive franchisee and retailer of new and used vehicles in the United States. The company sells new and used cars, and trucks; offers replacement parts; provides vehicle maintenance, warranty, paint, and repair services; and arranges related financing, service contracts, protection products, and credit insurance. As of February 22, 2013, the company offered 27 brands of new vehicles and various brands of used vehicles in 87 stores, as well as online at Lithia.com. Lithia Motors, Inc. was founded in 1946 and is based in Medford, Oregon.

Advisors' Opinion:

• [By Corinne Gretler]

  Fresnillo Plc soared 6.6 percent to a two-month high as precious metals gained. Prudential Plc climbed to the highest in more than two decades after posting a 22 percent jump in profit. Telekom Austria AG dropped 1.6 percent after reporting second-quarter earnings that missed analysts��projections. Ladbrokes Plc (LAD) slid 2.6 percent as JPMorgan Chase & Co. downgraded the U.K. gambling company.

• [By Inyoung Hwang]

  Ladbrokes (LAD) rallied 2.9 percent to 185 pence, posting the biggest two-day gain since April 2009. A mystery buyer, thought to be Sagi, bought a stake in the U.K. bookmaker, the Telegraph reported. The deal, through Shore Capital, was just below the 3 percent disclosure limit, according to the Telegraph. The purchase fueled speculation about a possible bid, the newspaper said.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Lithia Motors (NYSE: LAD  ) , whose recent revenue and earnings are plotted below.

Top 10 Managed Healthcare Companies To Invest In 2014: Provectus Pharmaceuticals Inc (PVCT)

Provectus Pharmaceuticals, Inc., incorporated on May 1, 1978, is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The Company develops and focuses to license or market and sells its two prescription drug candidates, PV-10 and PH-10. The Company has transferred all its intellectual property related to over the counter (OTC) products and non-core technologies to its subsidiaries and designated, such subsidiaries as non-core to its primary business of developing its oncology and dermatology prescription drug candidates. The Company focuses on developing its prescription drug candidates PV-10 and PH-10. The Company is developing PV-10 for treatment of several life threatening cancers, including metastatic melanoma, liver cancer, and breast cancer. The Company is developing PH-10 to provide minimally invasive treatment of chronic severe skin afflictions such as psoriasis and atopic dermatitis, a type of eczema. All of the Company's prescription drug candidates are in either the pre-clinical or clinical trial stage.

PV-10

As of December 31, 2011, the Company is developing PV-10, a sterile injectible form of rose bengal disodium (Rose Bengal), for direct injection into tumors. Its PV-10 is retained in diseased or damaged tissue but dissipates from healthy tissue. The Company had conducted Phase I and Phase IIstudies of PV-10 for the treatment of metastatic melanoma, and Phase I studies of PV-10 for the treatment of liver and breast cancers.

PH-10

The Company�� prescription drug candidate PH-10 is an aqueous hydrogel formulation of Rose Bengal for topical administration to the skin. The Company is developing PH-10 for the treatment of cutaneous skin disorders, specifically psoriasis and atopic dermatitis. In August 2011, the Company completed follow-up of all Phase IIc patients.

Over-the-Counter Pharmaceuticals

The Company had desi! gnated its subsidiary that holds its OTC products, GloveAid and Pure-ific, Pure-Stick, Pure N Clear as non-core. The Company�� GloveAid is a hand cream with both antiperspirant and antibacterial properties, for the comfort of users��hands during and after the wearing of disposable gloves. Its Pure-ific line of products includes two quick-drying sprays, Pure-ific and Pure-ific Kids, that immediately kill up to 99.9% of germs on skin and prevent regrowth for six hours. Pure-ific products prevent the spread of germs and thus complement its other OTC products designed to treat irritated skin or skin conditions, such as acne, eczema, dandruff and fungal infections. Its Pure-ific sprays have been designed with convenience in mind and are targeted towards mothers, travelers, and anyone concerned about the spread of sickness-causing germs.

The Company�� acne products Pure-Stick and Pure N Clear work by decreasing the production of fats, oils and sweat that create an environment conducive to unchecked growth of bacteria. Secondly, the products also act to reduce the number bacteria already present. The Pure-Stick and Pure N Clear are applied topically to affected areas there are no safety concerns with healthy skin.

Advisors' Opinion:

• [By Luke Jacobi]

  Provectus Biopharmaceuticals (NYSE: PVCT) was also down, falling 3.38 percent to $3.01, letting out some air after the company's opening on the NYSE Friday.

• [By Jake L'Ecuyer]

  Provectus Biopharmaceuticals (NYSE: PVCT) was also down, falling 3.02 percent to $3.01, letting out some air after the company's opening on the NYSE Friday.